The interaction of C–C motif chemokine receptor 7 (CCR7) with its ligand chemokine C–C motif ligand 21 (CCL21) drives the migration and accumulation of cross-presenting DCs in the lymph nodes, leading to T cell priming and tumor rejection [145]. Here, CCR7 is linked to neoplasm.